Portfolio Update

BLACKROCK GREATER EUROPE INVESTMENT TRUST plc All information is at 31 December 2011 and unaudited. Performance at month end with net income reinvested One Three One Three Since launch Month Months Year Years (20 Sep 04) Net asset value* (Undiluted) -0.9% 4.1% -17.2% 26.1% 93.8% Net asset value* (Diluted) -0.9% 4.1% -15.4% 26.1% 93.8% Share price -2.9% -1.4% -16.7% 25.5% 82.6% FTSE World Europe ex UK -1.5% 3.3% -14.7% 8.3% 57.3% Sources: BlackRock and Datastream * Net asset value and share price performance includes the subscription share reinvestment, assuming the subscription share entitlement per share was sold and the proceeds reinvested on the first day of trading. At month end Net asset value (capital only): 167.96p Net asset value (including income): 167.96p Net asset value (capital only)**: 167.96p Net asset value (including income)**: 167.96p Share price: 163.13p Discount to NAV (including income): 2.9% Discount to NAV (including income)**: 2.9% Subscription share price: 6.75p Gearing (including income): Nil Net yield: 2.2% Total assets (including income): £159.4m Ordinary shares in issue: 94,873,100*** Subscription shares in issue: 18,342,725 ** Diluted for subscription shares. *** Excluding 2,734,952 shares held in treasury. Benchmark Sector Analysis Total Assets (%) Index (%) Country Analysis Total Assets (%) Consumer Goods 27.6 17.6 Switzerland 21.3 Health Care 16.8 11.7 France 15.4 Industrials 15.7 13.6 Germany 14.0 Financials 11.3 19.1 Netherlands 10.5 Consumer Services 8.9 5.0 Denmark 5.6 Oil & Gas 6.3 10.0 Spain 3.4 Basic Materials 5.1 8.1 Sweden 3.4 Technology 2.4 3.3 Norway 3.0 Utilities 1.6 5.7 Belgium 3.0 Telecommunications 0.9 5.9 Ireland 2.5 Net current assets 3.4 - Finland 2.3 ----- ----- Italy 2.2 100.0 100.0 Portugal 2.0 ===== ===== Luxembourg 1.8 Czech Republic 1.6 Kazakhstan 1.4 Other 3.2 Net current assets 3.4 ----- 100.0 ===== Ten Largest Equity Investments (in alphabetical order) Company Country of Risk Ahold Netherlands Danone France DnB NOR Norway Fresenius Germany LVMH France Nestlé Switzerland Novo Nordisk Denmark Pernod Ricard France Roche Switzerland Syngenta Switzerland Commenting on the markets, Vincent Devlin, representing the Investment Manager noted: Market During the month, while the sovereign debt issues continued to dominate the headlines, better US economic data and recent Eurozone summit proposals provided some positive news. As a result, globally exposed cyclical sectors such as oil & gas performed best. Defensive areas provided a mixed result with health care delivering positive returns while telecoms and utilities ended in negative territory. Fund Performance & Attribution During December, the Company's NAV fell by 0.9% and the share price fell 2.9%. For reference, the FTSE World Europe ex UK Index was down 1.5% during the same period. Sector allocation delivered strong results during the month. At a sector level, lower weightings in the weaker-performing utilities and telecoms sectors contributed positively to performance. Specifically, avoiding power and gas company E.ON and telecoms group Telefónica, which cut its dividend forecast, was rewarding. Performance from the health care sector was mixed. A higher weighting in the sector was rewarding, whilst stock selection was detrimental to performance. Pharmaceuticals companies such as Roche and Novo Nordisk were amongst the top contributors to performance, although not holding Novartis and Sanofi detracted from returns when compared to the reference index as both companies performed well during the month. A number of holdings in relatively stable, consumer-related businesses proved successful. In particular, holdings in brewer Anheuser-Busch InBev and food retailer Ahold both benefited from improving trading conditions in the US. Food producer Nestlé also rallied following a period of share price weakness. On a less positive note, within the oil & gas sector, not owning oil major Total hurt performance. The portfolio was also impacted by stock-specific disappointment on the sale price achieved by energy company Galp for a stake in its Brazilian subsidiary. Following concerns over a hard landing in China, luxury goods companies lagged the market and a holding in LVMH hindered performance. During the month, the Company reduced its exposure to insurance through the sale of the holding in ING. The proceeds were recycled to initiate a new position in toll-road operator Abertis Infraestructuras. At the end of the month, the Company had higher weightings (when compared with the FTSE World Europe ex UK Index) in consumer goods, health care, consumer services and industrials and lower weightings in financials, telecoms, utilities, basic materials, oil & gas and technology. Outlook Moving into 2012, progress towards a resolution of the European sovereign debt issues will continue to shape investor sentiment and markets are likely to remain volatile. Investors are, however, pricing in a significant risk premium for the current political and economic uncertainties and we believe our strategy of building positions in the long term winners - companies with highly differentiated business models, strong balance sheets and structural growth driven largely by international demand - will deliver attractive returns over the medium term. Many of these companies' shares have been oversold in 2011 as the global economy has slowed but have started to benefit in Q4 from improving US macro data and continued demand for their exports from the rest of the world. In terms of domestic exposure, we are being very selective to find some attractive investments amongst stable businesses particularly in infrastructure-related sectors, trading at distressed valuations but with stable, growing free cash-flows. 19 January 2012 ENDS Latest information is available by typing www.blackrock.co.uk/its on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on the Manager's website (or any other website) is incorporated into, or forms part of, this announcement.
Investor Meets Company
UK 100